Download presentation
Presentation is loading. Please wait.
1
Intermediate Risk TAVR 1 Year Later
Stephen Bailey, MD Director, Division of Cardiac Surgery Allegheny General Hospital September 27, 2017
2
Disclosure The information provided is the experience of the Allegheny General Hospital, and Edwards Lifesciences has not independently evaluated these data. Outcomes are dependent upon a number of facility and surgeon factors which are outside Edwards’ control. These data should not be considered promises or guarantees by Edwards that the outcomes presented here will be achieved by an individual facility. Stephen Bailey is a paid consultant to Edwards Lifesciences
3
AGH
4
Intermediate Risk One Year Later
What is the opinion of heart team to IR? Impact of RCT data What is the view of referring physicians? What is the view of patients? How has IR impacted our program? What % of IR patients have TAVR? How have we accommodated growth?
5
AGH TAVR Surgical clinic 3-4 new patients 3-4 mornings/ week
CT/ TTE 4-5 TAVR every Monday + 2 Fridays/month
6
AGH OHS Volume
7
AGH OHS Volume
8
TAVR Access
9
DRG Breakdown per Year
10
Trend of Average STS scores
11
Impact of Intermediate risk
12
Impact of Intermediate Risk on Length of Stay
13
TAVR Complications (In-Hospital)
14
TAVR Anesthesia
15
ICU Hours
16
Intermediate Risk One Year Later
What is the opinion of heart team to IR? Impact of RCT data What is the view of referring physicians? What is the view of patients? How has IR impacted our program? What % of IR patients have TAVR? How have we accommodated growth?
17
Summary Intermediate risk came during ongoing evolution of evaluation and treatment protocols Overall risk profile of our patients trending slowly down (never knew there were so many 90 year olds) Program/ pathway refinement dovetailed nicely with IR approval to enhance financial performance
18
Thank you
19
Please see important safety information at the speaker’s podium
Edwards and Edwards Lifesciences are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners. PP--US-2342 v1.0
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.